ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.

S, Viviani; PL, Zinzani; A, Rambaldi; E, Brusamolino; A, Levis; V, Bonfante; U, Vitolo; A, Pulsoni; AM, Liberati; G, Specchia; P, Valagussa; A, Rossi; F, Zaja; EM, Pogliani; P, Pregno; M, Gotti; A, Gallamini; Scalabrini D, Rota; G, Bonadonna; AM, Gianni

doi:10.1056/nejmoa1100340

Public

ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.

Shared by NobleBlocks on Jul 1, 2011 • 12:00 AM UTC

Authors:

Viviani S

Zinzani PL

Rambaldi A

Abstract

<h4>Background</h4>BEACOPP, an intensified regimen consisting of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone, has been advocated as the new standard of treatment for advanced Hodgkin's lymphoma, in place of the combination of doxorubicin, bleomycin,...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!